SEAL ROCK THERAPEUTICS

Seal Rock Therapeutics is a developer of small-molecule inhibitors of ASK1 (Apoptosis signal-regulating kinase 1), a protein that mediates apoptosis, inflammation, and fibrosis. Seal Rock is currently focusing its efforts on hepatic indications including NASH (non-alcoholic steatohepatitis), a condition resulting from fatty liver disease, characterized by hepatic inflammation and cellular damage that lead to liver fibrosis. Additional opportunities with ASK1 inhibitors include cardiac, immunological, and neurodegenerative indications.

#People #Financial #Website #More

SEAL ROCK THERAPEUTICS

Social Links:

Linkedin

Industry:

Biotechnology Health Care Medical

Founded:

2016-01-01

Address:

Seattle, Washington, United States

Country:

United States

Website Url:

http://www.sealrocktx.com

Total Employee:

1+

Status:

Active

Contact:

786.453.0593

Email Addresses:

[email protected]

Total Funding:

0

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Euro Microsoft Exchange Online Office 365 Mail

Current Employees Featured

neil-mcdonnell_image

Neil McDonnell
Neil McDonnell Co-Founder & Chief Executive Officer @ Seal Rock Therapeutics
Co-Founder & Chief Executive Officer
2016-01-01

Founder

neil-mcdonnell_image

Neil McDonnell

Investors List

life-science-angels_image

Life Science Angels

Life Science Angels investment in Seed Round - Seal Rock Therapeutics

life-science-angels_image

Life Science Angels

Life Science Angels investment in Seed Round - Seal Rock Therapeutics

Official Site Inspections

http://www.sealrocktx.com

Host Informations
Whois Informations

Loading ...

More informations about "Seal Rock Therapeutics" on Search Engine